A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 Following Single Intravenous Dose Administration in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2015
Price : $35 *
At a glance
- Drugs Oliceridine (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Trevena
- 17 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Jul 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Jul 2014 to 1 Jul 2015.
- 20 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.